1. Resting state network mapping in individuals using deep learning.
- Author
-
Luckett PH, Lee JJ, Park KY, Raut RV, Meeker KL, Gordon EM, Snyder AZ, Ances BM, Leuthardt EC, and Shimony JS
- Abstract
Introduction: Resting state functional MRI (RS-fMRI) is currently used in numerous clinical and research settings. The localization of resting state networks (RSNs) has been utilized in applications ranging from group analysis of neurodegenerative diseases to individual network mapping for pre-surgical planning of tumor resections. Reproducibility of these results has been shown to require a substantial amount of high-quality data, which is not often available in clinical or research settings., Methods: In this work, we report voxelwise mapping of a standard set of RSNs using a novel deep 3D convolutional neural network (3DCNN). The 3DCNN was trained on publicly available functional MRI data acquired in n = 2010 healthy participants. After training, maps that represent the probability of a voxel belonging to a particular RSN were generated for each participant, and then used to calculate mean and standard deviation (STD) probability maps, which are made publicly available. Further, we compared our results to previously published resting state and task-based functional mappings., Results: Our results indicate this method can be applied in individual subjects and is highly resistant to both noisy data and fewer RS-fMRI time points than are typically acquired. Further, our results show core regions within each network that exhibit high average probability and low STD., Discussion: The 3DCNN algorithm can generate individual RSN localization maps, which are necessary for clinical applications. The similarity between 3DCNN mapping results and task-based fMRI responses supports the association of specific functional tasks with RSNs., Competing Interests: The Washington University in St. Louis may receive royalty income based on a technology developed by PL, JS, JL, EL, and BA and licensed by Washington University to Sora Neuroscience. That technology is used in this research. EL owns stock in Neurolutions, General Sensing, Osteovantage, Pear Therapeutics, Face to Face Biometrics, Caeli Vascular, Acera, Sora Neuroscience, Inner Cosmos, Kinetrix, NeuroDev, and Petal Surgical. Washington University has an equity ownership of Neurolutions. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Luckett, Lee, Park, Raut, Meeker, Gordon, Snyder, Ances, Leuthardt and Shimony.)
- Published
- 2023
- Full Text
- View/download PDF